Lampros is the cofounder, board member and CTO of Biomimedica Inc. a Stanford University spin-off that develops a new material platform for cartilage replacement targeting the treatment of osteoarthritis. At Biomimedica, Lampros has successfully helped raise several rounds of financing from angel and VC funds. Prior to Biomimedica, Lampros has cofounded Ostracon, a spin-off from the University of Ioannina to develop bone monitoring and healing applications and Medical Engineering Solutions, a medical design boutique firm. He also held an engineer position at NASA Ames Research center. Lampros holds a diploma in Mechanical Engineering from Aristoteles University and a MSc in Biomechanics from Stanford University where he has also completed his doctoral degree requirements.